These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 24788044

  • 1. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
    Cui J, Xi H, Cai A, Bian S, Wei B, Chen L.
    Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY.
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [Abstract] [Full Text] [Related]

  • 3. Wnt pathway is involved in advanced gastric carcinoma.
    Zhang H, Xue Y.
    Hepatogastroenterology; 2008 Dec; 55(84):1126-30. PubMed ID: 18705344
    [Abstract] [Full Text] [Related]

  • 4. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
    Liu H, Yan ZQ, Li B, Yin SY, Sun Q, Kou JJ, Ye D, Ferns K, Liu HY, Liu SL.
    J Ovarian Res; 2014 Sep 05; 7():87. PubMed ID: 25297608
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.
    Li B, Ge Z, Song S, Zhang S, Yan H, Huang B, Zhang Y.
    Pathol Oncol Res; 2012 Oct 05; 18(4):1039-45. PubMed ID: 22777918
    [Abstract] [Full Text] [Related]

  • 6. SOX7 modulates the progression of hepatoblastoma through the regulation of Wnt/β-catenin signaling pathway.
    Ge J, Zheng Q, Qu H, Zhao Z, Xu Y, Wang H, Gao H, Zhan J.
    J Cancer Res Ther; 2022 Apr 05; 18(2):370-377. PubMed ID: 35645102
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.
    Liu WG, Xu Q.
    Eur Rev Med Pharmacol Sci; 2019 Sep 05; 23(18):7905-7912. PubMed ID: 31599413
    [Abstract] [Full Text] [Related]

  • 9. Slit2 expression and its correlation with subcellular localization of β-catenin in gastric cancer.
    Shi R, Liu W, Liu B, Xu Z, Chen L, Zhang Z.
    Oncol Rep; 2013 Oct 05; 30(4):1883-9. PubMed ID: 23933755
    [Abstract] [Full Text] [Related]

  • 10. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY, Wang ZM, Li-Chen, Wang BL, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2010 Feb 05; 119(3):601-12. PubMed ID: 19301122
    [Abstract] [Full Text] [Related]

  • 11. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
    Liu H, Mastriani E, Yan ZQ, Yin SY, Zeng Z, Wang H, Li QH, Liu HY, Wang X, Bao HX, Zhou YJ, Kou JJ, Li D, Li T, Liu J, Liu Y, Yin L, Qiu L, Gong L, Liu SL.
    Sci Rep; 2016 May 18; 6():26136. PubMed ID: 27188720
    [Abstract] [Full Text] [Related]

  • 12. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
    Wang ZK, Liu J, Liu C, Wang FY, Chen CY, Zhang XH.
    J Gastroenterol Hepatol; 2012 Oct 18; 27(10):1629-34. PubMed ID: 22741528
    [Abstract] [Full Text] [Related]

  • 13. CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer.
    Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.
    Oncol Rep; 2013 Sep 18; 30(3):1137-42. PubMed ID: 23835524
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q, Ma X, Li Y, Song W, Zhang L, Shu Y, Wan B.
    J Cell Biochem; 2019 Mar 18; 120(3):2897-2907. PubMed ID: 30500980
    [Abstract] [Full Text] [Related]

  • 15. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
    Ma LG, Bian SB, Cui JX, Xi HQ, Zhang KC, Qin HZ, Zhu XM, Chen L.
    Int J Mol Med; 2016 Apr 18; 37(4):1039-48. PubMed ID: 26936013
    [Abstract] [Full Text] [Related]

  • 16. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
    Jia S, Qu T, Wang X, Feng M, Yang Y, Feng X, Ma R, Li W, Hu Y, Feng Y, Ji K, Li Z, Jiang W, Ji J.
    PLoS One; 2017 Apr 18; 12(4):e0175058. PubMed ID: 28422983
    [Abstract] [Full Text] [Related]

  • 17. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
    Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S.
    Hum Pathol; 2013 Nov 18; 44(11):2438-48. PubMed ID: 24011952
    [Abstract] [Full Text] [Related]

  • 18. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z, Xie J, Cai Y, Yang S, Chen Y, Wu H.
    Diagn Pathol; 2015 Jul 28; 10():128. PubMed ID: 26215716
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
    Zhang S, Xu J, Wang H, Guo H.
    Cancer Biomark; 2019 Jul 28; 24(4):429-437. PubMed ID: 30909185
    [Abstract] [Full Text] [Related]

  • 20. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB, Xu Y, Chen LG, Guan TP, Ma YY, He XJ, Xia YJ, Tao HQ, Shao QS.
    Eur J Surg Oncol; 2014 Mar 28; 40(3):318-24. PubMed ID: 24406159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.